Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

In theory, the principles of omnichannel – personalised content through the right channels to maximise customer experience – ...

And here lies the challenge for communicators: how do we effectively communicate an organisation’s approach to AI in a way ...

Big hats, no cattle When different people see the same thing differently, it’s often because they’re looking at different ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

For most of us working in healthcare communications, the best buzz is when the work has clearly reached those who are most in ...

Amgen’s Blincyto (blinatumomab) has been granted a licence extension by the Medicines and Healthcare products Regulatory ...

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...